Cargando…

Pharmacological dose ascorbic acid administration in relapsed refractory multiple myeloma patients

OBJECTIVE: High-dose ascorbic acid leads to the formation of highly reactive oxygen species due to the pro-oxidant effect, resulting in cell death; therefore, used as an additive treatment in several malignancies. We present the results obtained by administration of pharmacological dose of ascorbic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolaman, Ali Zahit, Turgutkaya, Atakan, Küçükdiler, Hilal Eroğlu, Selim, Cem, Yavaşoğlu, İrfan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637644/ https://www.ncbi.nlm.nih.gov/pubmed/34900576 http://dx.doi.org/10.1016/j.lrr.2021.100281

Ejemplares similares

Original Versus Generic Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma: Comparison of Efficacy and Adverse Events
por: Bolaman, Ali Zahit, et al.
Publicado: (2021)

Eyebrow Whitening Induced by Imatinib
por: Yavasoglu, Irfan, et al.
Publicado: (2020)

Chlorella-induced thrombocytopenia
por: Yavasoglu, Irfan, et al.
Publicado: (2018)

COVID-19-associated Evans syndrome: A case report and review of the literature
por: Turgutkaya, Atakan, et al.
Publicado: (2022)

Cabot ring-like faggot cells in acute promyelocytic leukemia
por: Yavasoglu, Irfan, et al.
Publicado: (2022)

Use of gemtuzumab ozogamicin in relapsed refractory acute myeloid leukemia: Multi-center real life data from Turkey
por: Küçükdiler, Ayşe Hilal Eroğlu, et al.
Publicado: (2021)

The relationship between red cell distribution width and prognostic scores in myelodysplastic syndrome
por: Turgutkaya, Atakan, et al.
Publicado: (2022)

Multiple Myeloma and Alkaline Phosphatase
por: Yavaşoğlu, İrfan, et al.
Publicado: (2015)

Masquerading of COVID-19 Infection as Primary Mediastinal Large B-Cell Lymphoma
por: Bolaman, Ali Zahit, et al.
Publicado: (2021)

Auer Rods Are Not Seen in Non-Neoplastic Cells
por: Yavaşoğlu, İrfan, et al.
Publicado: (2016)

Sweet Syndrome Associated with Ixazomib
por: Yavaşoğlu, İrfan, et al.
Publicado: (2021)

Pregnancy and immune thrombocytopenia: New trends
por: Yavaşoğlu, İrfan, et al.
Publicado: (2020)

Immunohistochemical evaluation of CD20 expression in patients with multiple myeloma
por: Yavasoglu, Irfan, et al.
Publicado: (2015)

Limb gangrene: The first sign of essential thrombocythemia
por: Bolaman, Ali Zahit, et al.
Publicado: (2020)

Inclusion Body in a Leukocyte in Crimean-Congo Hemorrhagic Fever
por: Bolaman, Zahit, et al.
Publicado: (2015)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma
por: Cengiz, Arzu, et al.
Publicado: (2018)

Rheumatoid Arthritis and Anti-Thyroid Antibodies
por: Yavasoglu, Irfan, et al.
Publicado: (2009)

Bone and Bone Marrow Involvement in Sarcoidosis
por: Sargın, Gökhan, et al.
Publicado: (2014)

Fertility-Preserving Treatment Options in Patients with Malignant Hematological Diseases
por: Küçük, Mert, et al.
Publicado: (2012)

Knowledge, Attitudes, and Practices of Hematologists Regarding Fertility Preservation in Turkey
por: Küçük, Mert, et al.
Publicado: (2013)

Penile Ulcer Atra Related in Patient with Acute Promyelocytic Leukemia
por: Yavasoglu, Irfan, et al.
Publicado: (2012)

Serum Bcl-2 Levels in Patients with β-Thalassemia Minor: A Pilot Study
por: Yavaşoğlu, İrfan, et al.
Publicado: (2014)

PB1796: DETERMINATION OF THE RELATIONSHIP BETWEEN NEXT GENERATION SEQUENCING AND FLOW CYTOMETRY RESULTS IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA
por: Yavasoglu, I., et al.
Publicado: (2022)

Bone Marrow Involvement in a Patient with Alpha Heavychain Disease: Response to Tetracycline Treatment
por: Bolaman, Zahit, et al.
Publicado: (2012)

Pharmacologic Ascorbate in Myeloma Treatment: Doses Matter
por: Violet, Pierre-Christian, et al.
Publicado: (2017)

Adrenal incidentaloma and the Janus Kinase 2 V617F mutation: A case-based review of the literature
por: Unubol, Mustafa, et al.
Publicado: (2013)

Lung Clear “Sugar” Cell Tumor and JAK V617F Positive Essential Thrombocythemia: a Simple Coincidence?
por: Yazak, Volkan, et al.
Publicado: (2013)

Relationship between glycemic control and histochemical myeloperoxidase activity in neutrophils in patients with type 2 diabetes
por: Unubol, Mustafa, et al.
Publicado: (2015)

The role of mean platelet volume in patients with non-specific abdominal pain in an emergency department
por: Coskun, Adil, et al.
Publicado: (2015)

Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms
por: Andıç, Neslihan, et al.
Publicado: (2016)

Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid
por: Xia, Jiliang, et al.
Publicado: (2017)

Repeat administration of high dose melphalan in relapsed myeloma.
por: Mansi, J. L., et al.
Publicado: (1993)

Fungal Infections and Myeloma: Supports
por: Yavaşoğlu, İrfan
Publicado: (2023)

The clinical activity of arsenic trioxide, ascorbic acid, ifosfamide and prednisone combination therapy in patients with relapsed and refractory multiple myeloma
por: Li, Xin, et al.
Publicado: (2015)

Bortezomib-Based Regimens and Plasma Cell Leukemia
por: Bolaman, Ali Zahit
Publicado: (2021)

Carfilzomib for relapsed and refractory multiple myeloma
por: Groen, K, et al.
Publicado: (2019)

Treatment of relapsed and refractory multiple myeloma
por: Lee, Ji Hyun, et al.
Publicado: (2020)

Selinexor in relapsed/refractory multiple myeloma
por: Richter, Joshua, et al.
Publicado: (2020)

The association between Hba1c and arterial stiffness among non-diabetic patients with chronic kidney disease
por: Turgutkaya, Atakan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iadefjbkjdflanbcv4rhej2vga